OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
Jinge Zhao, Nanwei Xu, Sha Zhu, et al.
Cancer Research (2023) Vol. 84, Iss. 1, pp. 154-167
Closed Access | Times Cited: 8
Jinge Zhao, Nanwei Xu, Sha Zhu, et al.
Cancer Research (2023) Vol. 84, Iss. 1, pp. 154-167
Closed Access | Times Cited: 8
Showing 8 citing articles:
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature
Rolf I. Skotheim, Mari Bogaard, Kristina Totland Carm, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189080-189080
Open Access | Times Cited: 6
Rolf I. Skotheim, Mari Bogaard, Kristina Totland Carm, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189080-189080
Open Access | Times Cited: 6
Intermediate risk prostate tumors contain lethal subtypes
William L. Harryman, James P. Hinton, Raquel Sainz, et al.
Frontiers in Urology (2025) Vol. 4
Open Access
William L. Harryman, James P. Hinton, Raquel Sainz, et al.
Frontiers in Urology (2025) Vol. 4
Open Access
Molecular complexity of intraductal carcinoma of the prostate
Sha Zhu, Nanwei Xu, Hao Zeng
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 3
Sha Zhu, Nanwei Xu, Hao Zeng
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 3
MDT perspective: intraductal carcinoma of the prostate: implication for diagnosis and treatment
Hao Zeng, Sha Zhu, Jing Li, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 2, pp. 242-243
Closed Access | Times Cited: 1
Hao Zeng, Sha Zhu, Jing Li, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 2, pp. 242-243
Closed Access | Times Cited: 1
Molecular Alterations in Intraductal Carcinoma of the Prostate
Marit Bernhardt, Glen Kristiansen
Cancers (2023) Vol. 15, Iss. 23, pp. 5512-5512
Open Access | Times Cited: 3
Marit Bernhardt, Glen Kristiansen
Cancers (2023) Vol. 15, Iss. 23, pp. 5512-5512
Open Access | Times Cited: 3
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations
Jing Hu, Xinyi Chen, Feifei Sun, et al.
Neoplasia (2024) Vol. 50, pp. 100983-100983
Open Access
Jing Hu, Xinyi Chen, Feifei Sun, et al.
Neoplasia (2024) Vol. 50, pp. 100983-100983
Open Access
Cribriform pattern 4/intraductal carcinoma of the prostate and persistent prostate‐specific antigen after radical prostatectomy
Takeshi Sasaki, Ikuo Kobayashi, Katsunori Uchida, et al.
BJUI Compass (2024) Vol. 5, Iss. 7, pp. 709-717
Open Access
Takeshi Sasaki, Ikuo Kobayashi, Katsunori Uchida, et al.
BJUI Compass (2024) Vol. 5, Iss. 7, pp. 709-717
Open Access
Assessing the predictive value of intraductal carcinoma of the prostate (IDC‐P) in determining abiraterone efficacy for metastatic hormone‐sensitive prostate cancer (mHSPC) patients
Xinyuan Wei, Jinge Zhao, Ling Nie, et al.
The Prostate (2024)
Open Access
Xinyuan Wei, Jinge Zhao, Ling Nie, et al.
The Prostate (2024)
Open Access
